Skip to contentClarengateINTELLIGENCE
Companies/09059325

Aptamer Therapeutics Limited

Research and experimental development on biotechnology · York

ActiveUnited KingdomIncorporated 2014Private Limited Company
Register Ask analyst

Financial position

Accounts to 2025-06-30 · GBP · Company accounts

Net assets
−£324,486
Cash
£888
Turnover
—
Profit / loss
—
Current assets
—
Creditors < 1 year
—
Equity
−£324,486
Average employees
2

Balance-sheet trend

GBP · company

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

10 periods
Reported figures2025-06-30Company2024-06-30Company2023-06-30Company2022-06-302020-03-312019-03-312018-03-312017-03-312016-03-312015-05-31
Balance sheet
Net assets−£324,486−£313,841−£304,218—−£96,159−£2,640£2,569£2,498−£2,424−£19
Equity−£324,486−£313,841−£304,218−£196,036−£96,159−£2,640£2,569£2,498−£2,424−£19
Assets
Fixed assets————£122,602—————
Property, plant & equipment£10,624£17,845————————
Current assets————£36,317£9£8£20£39£30
Cash at bank£888£1,157————————
Liabilities
Creditors within one year————£101,366£2,649£2,577£2,518£2,463£50
Net current assets————−£65,049−£2,640−£2,569−£2,498—−£20
Assets less current liabilities————£57,553−£2,640£2,569£2,498——
People
Average employees22——11————
Source evidenceView filing View filing View filing View filing View filing View filing View filing View filing View filing View filing

Secured borrowing

Registered charges, lenders and security interests.

Charges and related records

0 outstanding charges

No charges available in our records.